Rüsch D, Palm S, Sauerwald M, Römer T, Wulf H
Klinik für Anästhesiologie und Operative Intensivmedizin der Christian-Albrechts-Universität zu Kiel, Germany.
Anasthesiol Intensivmed Notfallmed Schmerzther. 2002 Jan;37(1):16-23. doi: 10.1055/s-2001-20002.
Compared to other procedures, gynaecological laparoscopies are followed rather frequently by postoperative nausea and vomiting (PONV). Therefore, we investigated the prophylactic antiemetic efficacy of metoclopramide and droperidol under general anaesthesia with isoflurane (part 1). Given the rather unsatisfying results of this monoprophylaxis we examined the effects of a quintuple prophylaxis in this setting (part 2).
Part 1: Following ethical committee approval and written informed consent 120 patients scheduled for elective gynaecological laparoscopy were allocated prospectively, randomly and observer-blinded to the following groups: group P (placebo): 2 ml NaCl 0.9 %, group D: 2.5 mg droperidol, group M: 10 mg metoclopramide. Part 2: Subsequently 50 patients scheduled for elective gynaecological laparoscopy and bearing a minimum risk of 25 % to experience postoperative vomiting were allocated prospectively and blinded to the observers to a quintuple prophylaxis group: group X: 10 mg metoclopramide, 2.5 mg droperidol, 12.5 mg dolasetron, 62.5 mg dimenhydrinate, 8mg dexamethasone. Part 1 and 2: Anaesthesia was induced with fentanyl, etomidate and succinycholine and maintained with isoflurane/N2O, fentanyl and cisatracurium. The antiemetics were applied intravenously 20 min prior to end of surgery.
Within the first 24 h postoperatively vomiting occurred more frequently in group P (44 %) compared to group D (21 %, p = 0.046) and group M (33 %, n. s.). Nausea also occurred more frequently in group P (61 %) compared to group D (24 %, p = 0.003) and group M (48 %, n. s.). Intensity of nausea was reduced both in group D and group M compared to group P (p = 0.03). Likewise the requirements for antiemetics as a rescue medication were reduced in group D (p = 0.02) and group M (p = 0.047) compared to group P. In group X no patient suffered from postoperative vomiting, no patient required a rescue antiemetic.
Whereas droperidol provides a reliable antiemetic effect, the prophylactic effect of metoclopramide is rather uncertain. Therefore, further studies regarding a dose response-relationship for metoclopramide are deemed necessary. Since a monoprophylaxis with droperidol or metoclopramide failed to attain a satisfying PONV-prophylaxis in patients at high risk for PONV, the quintuple antiemetic combination might be an effective and safe solution.
与其他手术相比,妇科腹腔镜手术后恶心呕吐(PONV)的发生率较高。因此,我们研究了甲氧氯普胺和氟哌利多在异氟烷全身麻醉下的预防性止吐效果(第一部分)。鉴于这种单一预防措施的效果不尽人意,我们在这种情况下研究了五联预防措施的效果(第二部分)。
第一部分:经伦理委员会批准并获得书面知情同意后,将120例计划进行择期妇科腹腔镜手术的患者前瞻性、随机且观察者盲法分配至以下组:P组(安慰剂):2ml 0.9%氯化钠溶液;D组:2.5mg氟哌利多;M组:10mg甲氧氯普胺。第二部分:随后,将50例计划进行择期妇科腹腔镜手术且术后呕吐风险至少为25%的患者前瞻性、观察者盲法分配至五联预防组:X组:10mg甲氧氯普胺、2.5mg氟哌利多、12.5mg多拉司琼、62.5mg茶苯海明、8mg地塞米松。第一部分和第二部分:麻醉诱导采用芬太尼、依托咪酯和琥珀胆碱,维持采用异氟烷/氧化亚氮、芬太尼和顺式阿曲库铵。止吐药在手术结束前20分钟静脉注射。
术后24小时内,P组呕吐发生率(44%)高于D组(21%,p = 0.046)和M组(33%,无统计学意义)。P组恶心发生率(61%)也高于D组(24%,p = 0.003)和M组(48%,无统计学意义)。与P组相比,D组和M组恶心强度均降低(p = 0.03)。同样,与P组相比,D组(p = 0.02)和M组(p = 0.047)作为急救药物的止吐药需求减少。X组无患者发生术后呕吐,无患者需要急救止吐药。
虽然氟哌利多具有可靠的止吐作用,但甲氧氯普胺的预防作用相当不确定。因此,认为有必要进一步研究甲氧氯普胺的剂量反应关系。由于单用氟哌利多或甲氧氯普胺预防未能在PONV高风险患者中获得满意的PONV预防效果,五联止吐联合用药可能是一种有效且安全的解决方案。